SATB1 and neoplasm: Moreover, the fact that HER ligands are not only expressed in tumor cells, but also in adjacent tumor stroma cells, indicates that effects obtained in ‘pure’ tumor cell models (even 3-D) may rather underestimate therapeutic efficacies of SATB1 inhibition.